Old Web
English
Sign In
Acemap
>
authorDetail
>
Myrthe J. van Dijk
Myrthe J. van Dijk
Utrecht University
Chemistry
Activator (genetics)
Disease
Pyruvate kinase
Pharmacology
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacodynamic Effects of AG-946, a Highly Potent Next-Generation Activator of Pyruvate Kinase, in Ex Vivo Treatment of Red Blood Cells from Sickle Cell Disease Patients
2021
Blood
Minke A.E. Rab
Myrthe J. van Dijk
Jennifer Bos
Brigitte A. van Oirschot
Johan Gerrits
Penelope A. Kosinski
Charles Kung
Judith J.M. Jans
Eduard J. van Beers
Lenny Dang
Richard van Wijk
Show All
Source
Cite
Save
Citations (0)
Safety and Efficacy of Mitapivat (AG-348), an Oral Activator of Pyruvate Kinase R, in Subjects with Sickle Cell Disease: A Phase 2, Open-Label Study (ESTIMATE)
2021
Blood
Myrthe J. van Dijk
Minke A.E. Rab
Anita W. Rijneveld
Erfan Nur
Marije Bartels
Judith J.M. Jans
Wouter W. van Solinge
Roger E.G. Schutgens
Richard van Wijk
Eduard J. van Beers
Show All
Source
Cite
Save
Citations (0)
1